Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Bukhari

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|January 7, 2021
COVID-19 and mortality in rare rheumatic diseases, a warning bell?James Galloway, Marwan Bukhari
Rheumatology (Oxford, England)|April 6, 2017
Twitter, #alternativefacts, careless whispers and RheumatologyMarwan Bukhari, James Galloway
Osteoporosis and Sarcopenia|April 23, 2019
Predictors of fragility fracture and low bone mineral density in patients with a history of parental fractureMrinalini Dey, Marwan Bukhari
Rheumatology (Oxford, England)|October 6, 2019
How rheumatologists assess disability in the current era needs an overhaul: focus on the Health Assessment QuestionnaireMarwan Bukhari, Alison Kent
Rheumatology (Oxford, England)|October 19, 2023
Exploring and addressing health inequalities in patients with a rheumatic disease: report of a roundtable discussionMarwan Bukhari, Ernest Choy
European Journal of Rheumatology|October 7, 2016
Increasing body fat mass reverses bone loss in osteopenia as detected by dual-energy X-ray absorptiometry scansWilliam P Hedges, Marwan Bukhari
Rheumatology (Oxford, England)|June 20, 2020
Real-life experience of tocilizumab use in COVID-19 patientsAnastasia-Vasiliki Madenidou, Marwan Bukhari
Rheumatology (Oxford, England)|December 20, 2015
2015 EULAR-ACR recommendations for polymyalgia rheumatica: the message and next stepsLauren Steel, Marwan Bukhari, Bhaskar Dasgupta
Rheumatology (Oxford, England)|October 21, 2020
The benefits and challenges of providing patient education digitallyDavid Walker, Ade Adebajo, Marwan Bukhari
Rheumatology Advances in Practice|May 9, 2022
Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study. ReplyMarwan Bukhari, Nicola Goodson, Maarten Boers
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|January 7, 2021
COVID-19 and mortality in rare rheumatic diseases, a warning bell?James Galloway, Marwan Bukhari
Rheumatology (Oxford, England)|April 6, 2017
Twitter, #alternativefacts, careless whispers and RheumatologyMarwan Bukhari, James Galloway
Osteoporosis and Sarcopenia|April 23, 2019
Predictors of fragility fracture and low bone mineral density in patients with a history of parental fractureMrinalini Dey, Marwan Bukhari
Rheumatology (Oxford, England)|October 6, 2019
How rheumatologists assess disability in the current era needs an overhaul: focus on the Health Assessment QuestionnaireMarwan Bukhari, Alison Kent
Rheumatology (Oxford, England)|October 19, 2023
Exploring and addressing health inequalities in patients with a rheumatic disease: report of a roundtable discussionMarwan Bukhari, Ernest Choy
European Journal of Rheumatology|October 7, 2016
Increasing body fat mass reverses bone loss in osteopenia as detected by dual-energy X-ray absorptiometry scansWilliam P Hedges, Marwan Bukhari
Rheumatology (Oxford, England)|June 20, 2020
Real-life experience of tocilizumab use in COVID-19 patientsAnastasia-Vasiliki Madenidou, Marwan Bukhari
Rheumatology (Oxford, England)|December 20, 2015
2015 EULAR-ACR recommendations for polymyalgia rheumatica: the message and next stepsLauren Steel, Marwan Bukhari, Bhaskar Dasgupta
Rheumatology (Oxford, England)|October 21, 2020
The benefits and challenges of providing patient education digitallyDavid Walker, Ade Adebajo, Marwan Bukhari
Rheumatology Advances in Practice|May 9, 2022
Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study. ReplyMarwan Bukhari, Nicola Goodson, Maarten Boers
Pageof 8